Ongoing research programmes
My ongoing research work includes evaluation of cardiovascular outcomes associated with the presence of drug resistant hypertension; the role of statin therapy in reducing cardiovascular morbidity and mortality among patients with chronic kidney disease; meta-analysis on incident cancer and metabolic syndrome; determinants of heart failure among hypertensive patients, and on differential blood pressure responses to antihypertensive agents among south Asian hypertensive patients. In addition I am involved in several ongoing trials, and studies, including ASCOT-ON, ASCOT-10, Harmony, PREMIUM, and some of the secondary research projects related to the ASCOT trial. I am also involved in doing several meta-analyses, including those on heart failure, bariatric surgery, and angioedema associated with ACE-inhibitors.
Recently, I have joined School of Public Health, and there I am involved in several projects on eHealth, and the use of apps and electronic monitoring devices to improve wellbeing and health, and exploring their role in primary and secondary prevention of the chronic diseases.
Some of the recently concluded research projects are :.
•Ethnic differences in response to first- and second-line antihypertensive agents.
•Effect of antihypertensive associated new onset diabetes on CVD morbidity and mortality
•Obesity prevention in children: A school based community health programme.
•Predictors of resistant hypertension among hypertensive patients in ASCOT-BPLA.
•ASCORE: An up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practices developed using the ASCOT trial database
see research publications: